Psicofarmaci e farmaci antiretrovirali

Translated title of the contribution: Psycotropic and antiretroviral drugs

E. Seminari, A. Sforzini, P. Villani, F. Barale, R. Maserati

Research output: Contribution to journalArticle

Abstract

Psychiatric comorbidity is common in HIV/AIDS patients and psychiatric disorders are found in a number of individuals, significantly higher than what is to be expected in the general population. The majority of psychotropic drugs interacts with antiretroviral drugs because of the common matabolization pathway in the liver's cytochrome P450 system. The use of tricyclic antidepressant with protease inhibitors may require dose reduction while serotonine selective reuptake inhibitors are better tolerated. Long half-life benzodiazepines as midazolam and triazolam may raise severe side effects, therefore other molecules with shorter half-life should be preferred. The use of antipsychotic drugs is associated to the tendency of HIV-positive patients to exhibit adverse affects, therefore the best course is to start with low doses and increase the dosage slowly and progressively. The association of antipsychotic drugs requires caution because of the increase in plasma concentrations of neuroleptics.

Original languageItalian
Pages (from-to)145-151
Number of pages7
JournalGiornale Italiano di Malattie Infettive
Volume5
Issue number3
Publication statusPublished - 1999

Fingerprint

Antipsychotic Agents
Psychiatry
Half-Life
HIV
Pharmaceutical Preparations
Triazolam
Tricyclic Antidepressive Agents
Midazolam
Psychotropic Drugs
Protease Inhibitors
Benzodiazepines
Cytochrome P-450 Enzyme System
Comorbidity
Acquired Immunodeficiency Syndrome
Liver
Population

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Psicofarmaci e farmaci antiretrovirali. / Seminari, E.; Sforzini, A.; Villani, P.; Barale, F.; Maserati, R.

In: Giornale Italiano di Malattie Infettive, Vol. 5, No. 3, 1999, p. 145-151.

Research output: Contribution to journalArticle

@article{ed35c084825e44bd9466e4d76395daf0,
title = "Psicofarmaci e farmaci antiretrovirali",
abstract = "Psychiatric comorbidity is common in HIV/AIDS patients and psychiatric disorders are found in a number of individuals, significantly higher than what is to be expected in the general population. The majority of psychotropic drugs interacts with antiretroviral drugs because of the common matabolization pathway in the liver's cytochrome P450 system. The use of tricyclic antidepressant with protease inhibitors may require dose reduction while serotonine selective reuptake inhibitors are better tolerated. Long half-life benzodiazepines as midazolam and triazolam may raise severe side effects, therefore other molecules with shorter half-life should be preferred. The use of antipsychotic drugs is associated to the tendency of HIV-positive patients to exhibit adverse affects, therefore the best course is to start with low doses and increase the dosage slowly and progressively. The association of antipsychotic drugs requires caution because of the increase in plasma concentrations of neuroleptics.",
keywords = "HIV, HIV-infection, Pharmacokinetics, Psycotropic drug",
author = "E. Seminari and A. Sforzini and P. Villani and F. Barale and R. Maserati",
year = "1999",
language = "Italian",
volume = "5",
pages = "145--151",
journal = "Giornale Italiano di Malattie Infettive",
issn = "1126-9952",
publisher = "U T E T SpA",
number = "3",

}

TY - JOUR

T1 - Psicofarmaci e farmaci antiretrovirali

AU - Seminari, E.

AU - Sforzini, A.

AU - Villani, P.

AU - Barale, F.

AU - Maserati, R.

PY - 1999

Y1 - 1999

N2 - Psychiatric comorbidity is common in HIV/AIDS patients and psychiatric disorders are found in a number of individuals, significantly higher than what is to be expected in the general population. The majority of psychotropic drugs interacts with antiretroviral drugs because of the common matabolization pathway in the liver's cytochrome P450 system. The use of tricyclic antidepressant with protease inhibitors may require dose reduction while serotonine selective reuptake inhibitors are better tolerated. Long half-life benzodiazepines as midazolam and triazolam may raise severe side effects, therefore other molecules with shorter half-life should be preferred. The use of antipsychotic drugs is associated to the tendency of HIV-positive patients to exhibit adverse affects, therefore the best course is to start with low doses and increase the dosage slowly and progressively. The association of antipsychotic drugs requires caution because of the increase in plasma concentrations of neuroleptics.

AB - Psychiatric comorbidity is common in HIV/AIDS patients and psychiatric disorders are found in a number of individuals, significantly higher than what is to be expected in the general population. The majority of psychotropic drugs interacts with antiretroviral drugs because of the common matabolization pathway in the liver's cytochrome P450 system. The use of tricyclic antidepressant with protease inhibitors may require dose reduction while serotonine selective reuptake inhibitors are better tolerated. Long half-life benzodiazepines as midazolam and triazolam may raise severe side effects, therefore other molecules with shorter half-life should be preferred. The use of antipsychotic drugs is associated to the tendency of HIV-positive patients to exhibit adverse affects, therefore the best course is to start with low doses and increase the dosage slowly and progressively. The association of antipsychotic drugs requires caution because of the increase in plasma concentrations of neuroleptics.

KW - HIV

KW - HIV-infection

KW - Pharmacokinetics

KW - Psycotropic drug

UR - http://www.scopus.com/inward/record.url?scp=0032757831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032757831&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0032757831

VL - 5

SP - 145

EP - 151

JO - Giornale Italiano di Malattie Infettive

JF - Giornale Italiano di Malattie Infettive

SN - 1126-9952

IS - 3

ER -